Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis

Next-generation sequencing (NGS) has reached the molecular diagnostic laboratories. Although the NGS technology aims to improve the effectiveness of therapies by selecting the most promising therapy, concerns are that NGS testing is expensive and that the ‘benefits’ are not yet in relation to these...

Descripción completa

Detalles Bibliográficos
Autores principales: van Amerongen, Rosa A, Retèl, Valesca P, Coupé, Veerle MH, Nederlof, Petra M, Vogel, Maartje J, van Harten, Wim H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102690/
https://www.ncbi.nlm.nih.gov/pubmed/27899957
http://dx.doi.org/10.3332/ecancer.2016.684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102690/
https://www.ncbi.nlm.nih.gov/pubmed/27899957
http://dx.doi.org/10.3332/ecancer.2016.684

Ejemplares similares